IL212544A0 - 7- hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same - Google Patents

7- hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same

Info

Publication number
IL212544A0
IL212544A0 IL212544A IL21254411A IL212544A0 IL 212544 A0 IL212544 A0 IL 212544A0 IL 212544 A IL212544 A IL 212544A IL 21254411 A IL21254411 A IL 21254411A IL 212544 A0 IL212544 A0 IL 212544A0
Authority
IL
Israel
Prior art keywords
benzoimidazole
hydroxy
same
inhibitors containing
methanone derivatives
Prior art date
Application number
IL212544A
Other languages
English (en)
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of IL212544A0 publication Critical patent/IL212544A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL212544A 2008-10-30 2011-04-28 7- hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same IL212544A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10980108P 2008-10-30 2008-10-30
PCT/US2009/052228 WO2010051085A1 (en) 2008-10-30 2009-07-30 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same

Publications (1)

Publication Number Publication Date
IL212544A0 true IL212544A0 (en) 2011-06-30

Family

ID=42129188

Family Applications (1)

Application Number Title Priority Date Filing Date
IL212544A IL212544A0 (en) 2008-10-30 2011-04-28 7- hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same

Country Status (14)

Country Link
US (1) US20110263566A1 (enExample)
EP (1) EP2364087A4 (enExample)
JP (1) JP2012507525A (enExample)
KR (1) KR20110079847A (enExample)
CN (1) CN102271514A (enExample)
AU (1) AU2009310310A1 (enExample)
BR (1) BRPI0919977A2 (enExample)
CA (1) CA2741988A1 (enExample)
CO (1) CO6361855A2 (enExample)
IL (1) IL212544A0 (enExample)
MX (1) MX2011004414A (enExample)
RU (1) RU2011121665A (enExample)
WO (1) WO2010051085A1 (enExample)
ZA (1) ZA201103964B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660438A1 (en) * 2006-08-10 2008-02-14 Oncotherapy Science, Inc. Genes and polypeptides relating to breast cancers
WO2010014794A1 (en) * 2008-07-30 2010-02-04 Oncotherapy Science, Inc. Benzoimidazole derivatives and glycogen synthase kinase-3 beta inhibitors containing the same
MX2011005369A (es) * 2008-11-20 2011-06-20 Oncotherapy Science Inc Inhibidores de glicogeno sintasa cinasa-3 beta que contienen derivados de 7-hidroxi-benzoimidazol-4-il-metanona.
CN101619058A (zh) * 2009-01-08 2010-01-06 上海交通大学 一种苯并咪唑-4-酰胺型衍生物
AR094053A1 (es) * 2012-12-18 2015-07-08 Actelion Pharmaceuticals Ltd Derivados de indol carboxamida como antagonistas del receptor p2x₇
CN105017221B (zh) * 2014-04-30 2019-05-28 中国医学科学院药物研究所 苯并咪唑衍生物及其制法和药物组合物与用途
JP6009135B1 (ja) * 2015-07-30 2016-10-19 第一三共株式会社 成人ｔ細胞白血病リンパ腫の治療及び／又は予防剤
KR102578297B1 (ko) 2015-07-30 2023-09-13 다이이찌 산쿄 가부시키가이샤 성인 t 세포 백혈병 림프종의 치료 및/또는 예방제
WO2019124608A1 (ko) * 2017-12-22 2019-06-27 경상대학교병원 4'-(p-톨루엔설포닐아미도)-4-하이드록시칼콘을 유효성분으로 함유하는 류마티스 관절염 예방 또는 치료용 약학 조성물
CN109320461B (zh) * 2018-12-12 2020-02-07 迪嘉药业集团有限公司 一种替米沙坦中间体的制备方法
CN114072407A (zh) 2019-04-02 2022-02-18 阿里戈斯治疗公司 靶向prmt5的化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288100B1 (en) * 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
US20040002524A1 (en) * 2002-06-24 2004-01-01 Richard Chesworth Benzimidazole compounds and their use as estrogen agonists/antagonists
WO2004065370A1 (en) * 2003-01-23 2004-08-05 Crystalgenomics, Inc. Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof

Also Published As

Publication number Publication date
US20110263566A1 (en) 2011-10-27
MX2011004414A (es) 2011-06-21
AU2009310310A2 (en) 2011-10-06
BRPI0919977A2 (pt) 2015-08-25
EP2364087A1 (en) 2011-09-14
RU2011121665A (ru) 2012-12-10
AU2009310310A1 (en) 2010-05-06
JP2012507525A (ja) 2012-03-29
WO2010051085A1 (en) 2010-05-06
CA2741988A1 (en) 2010-05-06
EP2364087A4 (en) 2012-05-30
KR20110079847A (ko) 2011-07-08
ZA201103964B (en) 2012-02-29
CN102271514A (zh) 2011-12-07
CO6361855A2 (es) 2012-01-20

Similar Documents

Publication Publication Date Title
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
IL219646A0 (en) Novelnaphthyridine derivatives and the use thereof as kinase inhibitors
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
IL212544A0 (en) 7- hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
IL210412A0 (en) Heterocyclic derivatives and uses thereof
IL201379A0 (en) Inhibitors iap
ZA201101586B (en) Aminotriazolopyridines and their use as kinase inhibitors
ZA201004055B (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
IL254218A0 (en) Pipedrine-bridged compounds of the quinoxaline-converted type and their use
ZA201009073B (en) Heterocyclic compound and use thereof
EP2200977A4 (en) F1F0-ATPASE INHIBITOR AND ASSOCIATED METHODS
IL212250A0 (en) Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
GB0803352D0 (en) Oligopeptidic compounds and uses thereof
IL212755A0 (en) Pyrazinopyrazines and derivatives as kinase inhibitors
ZA201005618B (en) Iap inhibitors
IL208771A0 (en) Iminopyridine derivatives and use thereof
ZA201101909B (en) Iap inhibitors
IL207223A0 (en) Pyrrolidinyl derivatives and uses thereof
IL208824A0 (en) Iminopyridine derivative and use thereof
EP2274294A4 (en) 5-DIMETHOXY FUMAGILLOL AND ITS DERIVATIVES
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
GB0813359D0 (en) Halfin and/or platerfin
GB0714941D0 (en) Inhibitors
IL206950A0 (en) Aminopiperidinyl derivatives and uses thereof
HK1152528A (en) Iminopyridine derivatives and use thereof